Summary
The clinical appearance of Crohn's disease (CD) is especially marked by nutritional deficits and insufficiencies. For a long time the goal of nutritional care was reduced to the readjustment of the nutritional status. The development and clinical use of controlled parenteral nutrition (TPN) and enteral nutritive solutions (EN) did not only emphasize this therapeutical issue, but furthermore showed positive effects on the conservative as well as on the surgical treatment concepts. Therefore today artifical nutritional support is a firm part of therapy in acute, active phases or in the contact of surgical management of CD. This is especially valid in children, where complications in general and growth failure in particular can be reduced. EN is the preferred feeding method in most of the cases, due to a lower complication rate and reduced cost when compared to TPN. The question regarding the importance of nutritional support as primary therapy has also been investigated. The results differ extensively, but point towards the conclusion that patients with solitary small bowel disease do profit from this therapeutical concept. Nevertheless it is unclear, how TPN or EN interfere in the pathophysiology or -biochemistry in this process. A question about reduction e.g. of allergic components of daily diet did stimulate new theories regarding the hypothesis of a possible causal relationship between diet and the pathogenesis of CD. Investigations on dietary habits and daily dietary therapy did not reveal an overall accepted dietary guideline. Nevertheless it seems obvious that dietary counselling has a positive effect on the disease process. It does appear, that today in the acute, active phase as well as in the long term management of Crohn's disease nutritional-care is an important therapeutical method.
Zusammenfassung
Das klinische Bild und der Krankheitsverlauf beim Morbus Crohn sind im besonderen durch generelle Ernährungsstörungen und Mangelzustände geprägt. Die Funktion der Ernährungstherapie wurde dabei lange Zeit fast ausschließlich in der Wiederherstellung der Ernährungsbilanz gesehen. Die Entwicklung und klinische Anwendung einer kontrollierten parenteralen Ernährung (TPN) und enteraler Nährstofflösungen (EN) hat diesem therapeutischen Ansatz Gewicht verliehen und zusätzlich positive Effekte für bestehende konservative wie chirurgische Behandlungsschemata gezeigt. So ist in der Behandlung des akuten Schubes der Erkrankung und im Rahmen des operativen Vorgehens heute die künstliche Ernährung ein fester Bestandteil der Therapie. Dies gilt insbesondere im Kindesalter, wo Komplikationsraten reduziert und Wachstumsstörungen effektiver behandelt werden können. Die EN hat dabei eine medrigere Komplikationsrate und ist kostengünstiger im Vergleich zur TPN. Auch die Frage nach der Bedeutung der künstlichen Ernährung als primäre Therapie ist gestellt worden. Umfangreiche Studien kommen zu unterschiedlichen Ergebnissen, die aber darauf hinweisen, daß insbesondere Patienten mit einem solitären Dünndarmbefall von diesen Behandlungsmethoden profitieren. Unklar bleibt, auf welche Weise die EN bzw. TPN die Pathophysiologie bzw. -biochemie des Krankheitsverlaufes beeinflussen. Dennoch haben Rückschlüsse auf eine mögliche Reduktion z. B. von Allergenen aus der täglichen Diät Theorien über einen möglichen Zusammenhang zwischen der Pathogenese des Morbus Crohn und der Ernährung neuen Antrieb gegeben. Untersuchungen zu Ernährungsgewohnheiten der Patienten und Therapiestudien haben aber zu keinen einheitlichen Ernährungsempfehlungen geführt. Dagegen scheint unbestritten, daß die Ernährungsberatung sich positiv auf den Krankheitsverlauf auswirkt. So ist festzustellen, daß sowohl im akuten Schub wie auch in der langfristigen Betreuung des Morbus Crohn die Ernährungstherapie heute eine wichtige Behandlungskomponente darstellt.
Similar content being viewed by others
Literatur
Acheson EC (1960) The distribution of ulcerative colitis and regional enteritis in United States veterans with particular reference to the Jewish religion. Gut 1:291–299
Almy TP (1959) In: Cecil RR, Loeb RS (eds) Textbook of medicine. Saunders, Philadelphia, p 842
Belli DC, Seidman E, Bouthillier L, Weber AM, Roy CC, Pletincx M, Beaulieu M, Morin CL (1988) Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 94:603–610
Bos LP, Weterman ET (1980) Total parenteral nutrition in Crohn's disease. World J Surg 4:163–166
Boumous G, Devroede GJ (1974) Effects of an elemental diet on human fecal flora. Gastroenterology 66:210–214
Brandes JW, Lorenz-Meyer H (1981) Zuckerfreie Diät: eine neue Perspektive zur Behandlung des Morbus Crohn? Z Gastroenterol 19:1–12
Calam J, Crooks PE, Walker RJ (1980) Elemental diets in the management of Crohn's perianal fistulae. JPEN 4:4–8
Carstensen J (1979) Food additives and their possible role in Crohn's disease. Z Gastroenterol [Suppl 7]:145–153
Clark ML (1986) Role of nutrition in inflammatory bowel disease: an overview. Gut 27:72–75
Crohn BB, Ginzburg L, Oppenheimer GD (1932) Regional ileitis. A pathological and clinical entity. JAMA 99:1323–1328
Cummings JH (1981) Short-chain fatty acids in the human colon. Gut 22:763–779
Dalziel TK (1913) Chronic interstitial enteritis. BMJ 2:106
Dickinson RJ, Ashton MG, Axon ATR, Smith RC, Yeung CK, Hill GL (1980) Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 79:1199–1204
Donowitz M (1985) Arachidonic acid metabolites and their role in inflammatory bowel disease. Gastoenterology 88:580–587
Driscoll RH Jr, Rosenberg IH (1978) Total parenteral nutrition in inflammatory bowel disease. Med Clin North Am 62:185–201
Elson CO, Layden TJ, Nemchausky BA, Rosenberg JL, Rosenberg IH (1980) An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig Dis Sci 25:42–48
Erickson KL (1986) Dietary-fat modulation of immuneresponse (review). Int J Immunopharmacol 8:529–543
Fischer AW, Lürmann D (1933) Über eine tumorbildende, ulceröse stenosierende und perforierende Entzündung des unteren Ileums. Langenbecks Arch Chir 177:638
Fischer JE, Foster GS, Abel RM, Abbott WM, Ryan JA (1973) Hyperalimentation as primary therapy for inflammatory bowel disease. Am J Surg 125:165–175
Göschke H (1980) Die Behandlung intestinaler Fisteln mit ballastfreien Formel-Diäten. Aktuel Ernährungsmed 5:117–119
Greenberg GR, Fleming CR, Jeejeehboy KN, Rosenberg IH, Sales D, Tremaine WJ (1988) Controlled trial of bowel rest and nutritional support in the management of Crohn's disease. Gut 29:1309–1315
Guthy E (1982) Morbus Crohn und Nahrungsfette. Dtsch Med Wochenschr 107:71–73
Guthy E (1983) Ätiologie des Morbus Crohn. Dtsch Med Wochenschr 108:1729–1733
Harries AD, Jones IA, Danis V, Fifield R, Heatly RV, Newcombe RG, Rodes J (1983) Controlled trial of supplemented oral nutrition in Crohn's disease. Lancet I: 887–890
Harres AD, Danis VA, Heatley RV (1984) Influence of nutritional status on immune functions in patients with Crohn's disease. Gut 25:465–472
Heaton KW, Thornton JR, Emett PM (1979) Treatment of Crohn's disease with an undefined carbohydrate fibre rich diet. BMJ 2:746–766
Heckers H, Melcher FW, Kamenich W, Henneking K (1988) Chemisch aufbereitetes Fett und Morbus Crohn. Eine Pilotstudie zum Vorkommen von trans-Fettsäuren im Unterhautfettgewebe von Crohn-Patienten im Vergleich mit gesunden Kontrollen als Parameter des Langzeit-Fettverzehrs. Z Gastroenterol 26:259–264
Hodges PE, Thomson ABR (1982) Nutritional status of patients with Crohn's disease. Part 1. Can Diet Assoc 43:100–119
Imes S, Pinchbeck BR, Dinwoodie A, Walker K, Thomson ABR (1987) Iron, folate, vitamin B-12, zinc, and copper status in out-patients with Crohn's disease: effect of diet counseling. J Am Diet Assoc 87:928–930
Imes S, Pinchbeck B, Thomson ABR (1988) Diet counselling improves the clinical course of patients with Crohn's disease. Digestion 39:7–19
Jaernerot G, Jaernmark I, Nilsson K (1983) Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis or irritable bowel syndrome. Scand J Gastroenterol 18:999–1012
Jenkins AP, Treasure J, Thomson RPH (1988) Crohn's disease presenting as anorexia nervosa. BMJ 296:699–701
Jones A, Workman E, Freeman AH, Dickinson RJ, Wilson AJ, Hunter JO (1985) Crohn's disease. Maintenance of remission by diet. Lancet 1:177–180
Jones VA (1987) Comparison of total parenteral nutrition and elemental diet in induction of remission of Crohn's disease. Long-term maintenance of remission by personalized food exclusion diets. Dig Dis Sci 32 [Suppl]:100–107
Kasper H (1987) Ernährungsmedizin und Diätetik. 6. Aufl. Urban und Schwarzenberg, München Wien Baltimore
Kirchmann HMA (1987) Die Bedeutung von Elementardiäten in der Therapie des Morbus Crohn im Kindesalter. Monatsschr Kinderheilkd 135:666–671
Kirsner BS, Klich JR, Kalman SS, De Favaro MV, Rosenberg IH (1981) Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterology 80:10–15
Kirsner JB (1985) Inflammatory bowel disease at the University of Chicago — the first 50 years: some personal reflections. Am J Gastroenterol 80:219
Koga T, Nishida T, Miwa H, Yamamoto M, Kaku K, Yao AT, Okumura M (1984) Effects of dietary butter fat on fecal bile acid excretion in patients with Crohn's disease on elemental diet. Dig Dis Sci 29:994–999
Leijonmarck CE, Bergstrand LO, Carlstedt-Duke B, Gustafsson A, Midtvedt AC, Norin KE, Saxerholt H, Midtvet T (1988) Total parenteral nutrition and the function of the intestinal microflora in Crohn's disease. Scand J Gastroenterol 23: 59–64
Lochs H, Meryn S, Marosi L, Ferenci P, Hortnagl H (1983) Has total bowel rest a beneficial effect in the treatment of Crohn's disease? Clin Nutr 2:61–64
Lochs H, Egger-Schodl M, Schuh R (1984) Is tube feeding with elemental diets a primary therapy of Crohn's disease? Klin Wochenschr 62:821–825
Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H, Jeschinsky H (1984) European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology 86:249–266
Malchow H, Steinhardt HJ, Lorenz-Meyer H, Strohm WD, Rasmussen S, Sommer H, Jarnum S, Brandes JW, Leonhardt H, Ewe K, Jesdinsky H (1990) Feasibility and effectiveness of a defined-formula diet regimen in treating active Crohn's disease. European Cooperative Crohn's Disease Study III. Scand J Gastroenterol 25:235–244
Martini GA, Brandes JW (1976) Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 54:367–371
McCay PB (1983) Dietary fat and cancer: an overview. In: Roe DA (ed) Diet, nutrition and cancer. Liss, New York, pp 8–16
McDonald PJ, Fazio VW (1988) What can Crohn's patients eat? Eur J Clin Nutr 42:703–708
McIntyre PB, Powell-Tuck J, Wood SR, Lennard-Jones JE, Lerebours E, Hecketsweiler P, Galmiche J-P, Colin R (1986) Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 27:481–485
Mekhjian HS, Surtz DM, Watts HD, Deren JL, Katon RM, Beman FM (1979) National Cooperative Crohn's Disease Study: factors determining recurrence of Crohn's disease after surgery. Gastroenterology 77:907–913
Mendeloff AI, Calkins BM (1988) The epidemiology of idiopathic inflammatory bowel disease. In: Kirsner JB, Shorter RG (eds) Inflammatory bowel disease, 3rd edn. Lea and Febiger, Philadelphia, pp 3–35
Meryn S (1986) Die Rolle der Ernährung in der Akut- und Langzeittherapie chronisch-entzundlicher Darmerkrankungen. Wien Klin Wochenschr 98:774–779
Morin CL, Ling V, Bourassa D (1980) Small intestinal and colonic changes induced by a chemically defined diet. Dig Dis Sci 25:123–128
Mullen JL, Hargrove WC, Dudrick SH, Fitts WT Jr, Rosato EF (1978) Ten years experience with intravenous hyperalimentation and inflammatory bowel disease. Ann Surg 187:523–529
Müller JM, Keller HW, Erasmi H, Pichlmaier H (1983) Total parenteral nutrition as the sole therapy in Crohn's disease — a prospective study. Br J Surg 70:40–43
Nagel E, Guthy E, Schattenfroh S, Pohlenz J, Pichlmayr R (1988) Zur Pathogenese des Morbus Crohn. Schweiz Med Wochenschr 118:766–769
Nagel E (1989) Zur Bedeutung von Nahrungsfetten in der Pathogenese des Morbus Crohn: tierexperimentelle Studien an Schweinen. Z Gastroenterol 24:7–9
Nuboer JF (1932) Chronische phlegmone van het ileum. Ned Tijdschr Geneeskd 76:2989
O'Morain C (1982) Studies on the pathogenesis and treatment of Crohn's disease. MD thesis, National University of Ireland
O'Morain C, Segal AW, Levi AJ (1980) Elemental diets in treatment of acute Crohn's disease. BMJ 281:1173–1175
O'Morain C, Segal AW, Levi AJ (1984) Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. BMJ 288:1859–1862
Ostro MJ, Greenberg GR, Jeejeehboy KN (1985) Total parenteral nutrition and complete bowel rest in the management of Crohn's disease. JPEN 9:280–287
Payne-James JJ, Silk DBA (1988) Total parenteral nutrition as primary treatment in Crohn's disease — RIP? Gut 29:1304–1308
Persson PG, Ahlbom A, Hellers G (1987) Crohn's disease and ulcerative colitis. A review of dietary studies with emphasis on methodologic aspects. Scand J Gastroenterol 22:385–389
Purrmann J, Miller B, Strohmeyer G (1986) Zur Ätiologie chronisch-entzündlicher Darmerkrankungen. Z Gastroenterol 24:357–363
Rabast U, Heskamp R (1986) Adjuvante Therapie mit Formeldiäten bei chronisch-entzündlichen Darmerkrankungen. DMW 111:293–297
Ritchie JK, Wadsworth J, Lennard-Jones JE, Rogers E (1987) Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn's disease. BMJ 295:517–520
Rivilis J, MacArdle AM, Wlodek GK, Gurd FN (1973) Effect of an elemental diet on gastric secretion. Am J Surg 179:226–229
Rocchio MA, Cha CM, Haas KF, Randall HT (1974) Use of chemically defined diets in the management of patients with acute inflammatory bowel disease. Am J Surg 127:469–475
Rowe H, Rowe A Jr, Uyeyama K (1953) Regional enteritis —its allergic aspects. Gastroenterology 23: 554–571
Ruckdeschel G (1980) Darmflora und Elementardiät. Aktuel Ernährungsmed 5:81–88
Schacky C v, Fischer S, Lorenz R, Weber PC (1987) N-3-Fettsäuren, Eikosanoide und zelluläre Funktionen. Hämostaseologie 7:101–108
Shiloni E, Coronado E, Freund HR (1989) Role of total parenteral nutrition in the treatment of Crohn's disease. Am J Surg 157:180–185
Silk DBA, Payne-James J (1989) Inflammatory bowel disease: nutritional implications and treatment. Proc Nutr Soc 48:355–361
Sitzmann J v, Converse RL Jr, Bayless TM (1990) Favorable response to parenteral nutrition and medical therapy in Crohn's colitis. A report of 38 patients comparing severe Crohn's and ulcerative colitis. Gastroenterology 99:1647–1652
Sonnenberg A (1988) Geographic and temporal variations of sugar and margarine consumption in relation to Crohn's disease. Digestion 41:161–171
Scuba WW, Smith RJ, Wilmore DW (1985) Glutamine metabolism by the intestinal tract. JPEN 9:608–617
Stange EF, Schmid U, Fleig WE, Ditschuneit H (1990) Ausschlußdiät bei Morbus Crohn: eine kontrollierte, randomisierte Studie. Z Gastroenterol 28:561–564
Steinhardt HJ, Loeschke K, Kasper H, Holtermüller KH, Schäfer H (1985) European Cooperative Crohn's Disease Study (ECCDS): clinical features and natural history. Digestion 31:97–108
Steinhardt HJ (1987) Ernährungstherapie bei chronischentzündlichen Darmerkrankungen. Med Welt 38:634–638
Stephens RV, Randall HT (1969) Use of a concentrated, balanced, liquid elemental diet for nutritional management of catabolic states. Ann Surg 170:642–667
Summers RW, Switz DM, Sessions JT, Becktel JM Jr, Best WR, Kern F Jr, Singleton JW (1979) National Cooperative Crohn's Disease Study: result of drug treatment. Gastroenterology 77:847–869
Teahon K, Bjarnason I, Levi AJ (1988) Elemental diets in the management of Crohn's disease — a 10 year review. Gastroenterology 94: A457
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagel, E., Canzler, H. & Pichlmayr, R. Welche Rolle spielt die Ernährung beim Morbus Crohn? Ein Beitrag zur Bedeutung der diätetischen Therapie der Enteritis regionalis. Langenbecks Arch Chir 376, 238–246 (1991). https://doi.org/10.1007/BF00186819
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00186819